Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to -$2.2 million.

  • Cross Country Healthcare's Cash from Investing Activities fell 9492.88% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.6 million, marking a year-over-year increase of 533.23%. This contributed to the annual value of -$8.7 million for FY2024, which is 3674.05% up from last year.
  • As of Q3 2025, Cross Country Healthcare's Cash from Investing Activities stood at -$2.2 million, which was down 9492.88% from -$2.0 million recorded in Q2 2025.
  • Cross Country Healthcare's 5-year Cash from Investing Activities high stood at -$1.1 million for Q3 2024, and its period low was -$37.1 million during Q4 2022.
  • For the 5-year period, Cross Country Healthcare's Cash from Investing Activities averaged around -$5.6 million, with its median value being -$2.5 million (2024).
  • As far as peak fluctuations go, Cross Country Healthcare's Cash from Investing Activities crashed by 162028.8% in 2021, and later soared by 9333.49% in 2022.
  • Over the past 5 years, Cross Country Healthcare's Cash from Investing Activities (Quarter) stood at -$4.7 million in 2021, then tumbled by 691.95% to -$37.1 million in 2022, then surged by 92.25% to -$2.9 million in 2023, then grew by 11.97% to -$2.5 million in 2024, then increased by 13.43% to -$2.2 million in 2025.
  • Its last three reported values are -$2.2 million in Q3 2025, -$2.0 million for Q2 2025, and -$1.9 million during Q1 2025.